2024 CMR Board Exam Review Course

2024 CMR Board Exam Review Course

Society for Cardiovascular Magnetic Resonance CMR Board Exam Review Course

Format (Online Live, Online In-Person, Enduring, etc.) Online Virtual Webinar Meeting Dates Live: 20-21 April 2024

Meeting Location: Virtual

 

Acknowledgement of Financial Commercial Support

No financial commercial support was received for this educational activity.

Acknowledgement of In-Kind Support

No financial commercial support was received for this educational activity.

Satisfactory Completion

Learners must complete an evaluation form to receive a certificate of completion. Your chosen sessions must be attended in their entirety. Partial credit for individual sessions is not available. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

Stated Practice Gap(s)

Knowledge Gap: Practitioners may lack comprehensive knowledge, skills, and abilities in preparing patients for CMR studies, selecting appropriate protocols, conducting CMR studies in various scenarios, post-processing images, and interpreting results for clinical decision-making.

Protocol Selection Gap: Physicians may lack the ability to select and perform appropriate protocols for specific clinical scenarios, including understanding when and how to apply different protocols based on patient characteristics and clinical indications.

Interpretation Gap: Practitioners need further training in interpreting normal and abnormal CMR exams, including anatomy, function, and physiology in order to be able to recognize patterns indicative of ischemic and nonischemic heart disease, as well as interpreting additional CMR exams such as those for cardiac masses, congenital heart disease, and vascular disease.

Post-Processing Gap: There is a lack of essential training in the ability to supervise and/or perform post-processing tasks related to CMR exams, which are critical for generating accurate and clinically relevant results.

Certification Preparation Gap: Practitioners may lack preparation specifically for passing the CBCMR Exam, which requires a deep understanding of the above-mentioned areas.

Learning Needs:

  1. Comprehensive Knowledge of CMR Studies: Practitioners need training to develop a comprehensive understanding of CMR studies, including the principles of CMR imaging, patient preparation techniques, and the ability to select appropriate protocols for different clinical scenarios.
  2. Protocol Selection Skills: Physicians require training to enhance their ability to select and perform appropriate protocols for specific clinical scenarios. This includes understanding the criteria for selecting protocols based on patient characteristics and clinical indications.
  3. Interpretation Skills: Practitioners need further training in interpreting normal and abnormal CMR exams. This includes understanding anatomy, function, and physiology related to CMR, as well as recognizing patterns indicative of various heart diseases and other conditions.
  4. Post-Processing Skills: There is a need for training in supervising and performing post-processing tasks related to CMR exams. This training is essential for generating accurate and clinically relevant results.
  5. Certification Preparation: Practitioners require preparation specifically for passing the CBCMR Exam. This preparation should focus on deepening their understanding of CMR imaging principles, protocol selection, image interpretation, and post-processing tasks.
  6. Clinical Decision-Making Skills: Training should focus on developing skills related to using CMR imaging results for clinical decision-making. This includes understanding how to integrate CMR findings into patient management plans.
  7. Continuing Education: Practitioners should engage in ongoing education to stay updated with advancements in CMR imaging technology, protocols, and interpretation techniques.

 

Expected Results Statement:

Upon completion of the training program, practitioners will demonstrate comprehensive knowledge, skills, and abilities in cardiovascular magnetic resonance (CMR) imaging. They will be able to prepare patients effectively for CMR studies, select and perform appropriate protocols for various clinical scenarios, interpret normal and abnormal CMR exams accurately, supervise and perform post-processing tasks related to CMR imaging, and integrate CMR findings into clinical decision-making processes. Additionally, practitioners will be prepared to pass the CBCMR Exam, showcasing their deep understanding of CMR principles and practices. Overall, practitioners will be equipped to provide high-quality CMR imaging services, leading to improved patient care and outcomes.

Learning Objectives:

At the conclusion of this meeting, participants will have improved competence and professional performance in their ability to:

  1. Select and perform appropriate protocols for specific clinical scenarios.
  2. Perform CMR exams.
  3. Interpret normal and abnormal CMR exams: anatomy, function, and physiology.
  4. Interpret ischemic and nonischemic heart disease CMR Exams
  5. Interpret additional CMR exams including cardiac masses, congenital heart disease, and vascular disease.
  6. Supervise and/or perform post processing tasks.

Accreditation Statement

Society for Cardiovascular Magnetic Resonance (SCMR) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

SCMR designates this live/virtual activity for a maximum of 17.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflict of Interest

The following planners/reviewers who were in a position to control the content of this CME activity have disclosed the following financial relationships with ACCME defined ineligible companies. Planners/reviewers not listed below did not have any financial relationships to disclose.

 

First Name

Last Name

Individual's Role(s) in Activity

Name(s) of Ineligible Companies

Nature of Relevant Financial Relationship(s)

Method of Mitigation

 

Vanessa

Ferreira

Speaker, Chair, Planning Committee

General Electric Healthcare

Research Grant Site Principal Investigator

The COI subcommittee has reviewed all financial disclosures and the content of this activity and determine that no conflict is present

Kate

Hanneman

Speaker, Planning Committee

Sanofi Genzyme

Speakers Bureau

The COI subcommittee has reviewed all financial disclosures and the content of this activity and determine

that no conflict is present

Kanae

Mukai

Speaker, Planning Committee

Canon Medical Systems

Speakers Bureau

The COI subcommittee has reviewed all financial disclosures and the content of this activity and determine

that no conflict is present

Ming Yen

Ng

Speaker, Planning Committee, Chair

GE, BAYER

Other,Other

The COI subcommittee has reviewed all financial disclosures and the content of this activity and determine

that no conflict is present

Prabhakar

Rajiah

Speaker, Moderator, Planning Committee

Elsevier

Other

The COI subcommittee has reviewed all financial disclosures and the content of this activity and determine

that no conflict is present

Kevin

Steel

Speaker, Planning Committee

NA

NA

The COI subcommittee has reviewed all financial disclosures and the content of this activity and determine

that no conflict is present

Katie

Thomas

Speaker, Planning Committee

NA

NA

The COI subcommittee has reviewed all financial disclosures and the content of this activity and determine

that no conflict is present

Rachel

Wald

Speaker, Planning Committee

NA

NA

The COI subcommittee has reviewed all financial disclosures and the content of this activity and determine

that no conflict is present

 

The following faculty (presenters, moderators, chairs, etc.) who were in a position to control the content of this CME activity have disclosed the following financial relationships with ACCME defined ineligible companies. Faculty not listed below did not have any financial relationships to disclose.

 

First Name

Last Name

Individual's Role(s) in Activity

Name(s) of Ineligible

Companies

Nature of Relevant Financial

Relationship(s)

Method of Mitigation

Nay

Aung

Moderator/Speaker

NA

NA

The COI subcommittee has reviewed all financial disclosures and the content of this activity and determine

that no conflict is present

Sonya

Babu- Narayan

Moderator/Speaker

NA

NA

The COI subcommittee has reviewed all financial disclosures and the content of this activity and determine

that no conflict is present

 

James

Carr

Speaker

Siemens,RoClub,GE,Bay er,Guerbet

Research Grant Site Principal Investigator,Scientific/Me dical Advisory Board Member,Scientific/Medic al Advisory Board Member,Scientific/Medic al Advisory Board Member,Research Grant

Site Principal Investigator

The COI subcommittee has reviewed all financial disclosures and the content of this activity and determine that no conflict is present

Erica

Dall'Armellin a

Moderator

NA

NA

The COI subcommittee has reviewed all financial disclosures and the content of this activity and determine

that no conflict is present

Alison

Fletcher

Speaker

NA

NA

The COI subcommittee has reviewed all financial disclosures and the content of this activity and determine

that no conflict is present

Marianna

Fontana

Speaker

Consultancy/advisoy boards for Alnylam, Alexion, Astrazeneca, Bridgbio/Eidos, Prothena, Attralus, Intellia, Ionis, Cardior, Lexeo, Pfizer. Research grants from: Alnylam, Bridgbio, Astrazeneca, Pfize,Shares: Lexeo,

Mycardium-AI

Consultant,Private Stock Shareholder

The COI subcommittee has reviewed all financial disclosures and the content of this activity and determine that no conflict is present

Marco

Francone

Speaker

NA

NA

The COI subcommittee has reviewed all financial disclosures and the content of this activity and determine

that no conflict is present

Matthias

Friedrich

Speaker

NA

NA

The COI subcommittee has reviewed all financial disclosures and the content of this activity and determine

that no conflict is present

Edward

Hulten

Moderator

NA

NA

The COI subcommittee has reviewed all financial disclosures and the content of this activity and determine

that no conflict is present

Ron

Jacob

Moderator

Circle CV1

Other

The COI subcommittee has reviewed all financial disclosures and the content of this activity and determine

that no conflict is present

Dinesh

Kalra

Speaker

NA

NA

The COI subcommittee has reviewed all financial disclosures and the content of this activity and determine

that no conflict is present

Peter

Kellman

Moderator/Speaker

NA

NA

The COI subcommittee has reviewed all financial disclosures and the content of this activity and determine

that no conflict is present

Christopher

Kramer

Speaker

BMS,Cytokinetics,Biom arin

Research Grant Site Principal Investigator,Research

The COI subcommittee has reviewed all financial disclosures and the content of

 

 

 

 

 

Grant Site Principal Investigator,Scientific/Me dical Advisory Board

Member,Consultant

this activity and determine that no conflict is present

Steve

Leung

Speaker

NA

NA

The COI subcommittee has reviewed all financial disclosures and the content of this activity and determine

that no conflict is present

Chris

Macgowan

Speaker

NA

NA

The COI subcommittee has reviewed all financial disclosures and the content of this activity and determine

that no conflict is present

Viviana

Maestrini

Speaker

NA

NA

The COI subcommittee has reviewed all financial disclosures and the content of this activity and determine

that no conflict is present

Charlotte

Manisty

Speaker

MycardiumAI,Pfizer,Ab bott St Jude Medical

Corporate Board Member,Speakers Bureau,Speakers Bureau

The COI subcommittee has reviewed all financial disclosures and the content of this activity and determine

that no conflict is present

Pier Giorgio

Masci

Speaker

NA

NA

The COI subcommittee has reviewed all financial disclosures and the content of this activity and determine

that no conflict is present

Rebecca

Mills

Speaker

NA

NA

The COI subcommittee has reviewed all financial disclosures and the content of this activity and determine

that no conflict is present

Michael

Morris

Moderator

NA

NA

The COI subcommittee has reviewed all financial disclosures and the content of this activity and determine

that no conflict is present

Kristian

Mortensen

Speaker

NA

NA

The COI subcommittee has reviewed all financial disclosures and the content of this activity and determine

that no conflict is present

Saul

Myerson

Speaker

NA

NA

The COI subcommittee has reviewed all financial disclosures and the content of this activity and determine

that no conflict is present

Faisal

Nabi

Speaker

NA

NA

The COI subcommittee has reviewed all financial disclosures and the content of this activity and determine

that no conflict is present

Ntobeko

Ntusi

Speaker

NA

NA

The COI subcommittee has reviewed all financial disclosures and the content of this activity and determine

that no conflict is present

Karen

Ordovas

Speaker

NA

NA

The COI subcommittee has reviewed all financial disclosures and the content of this activity and determine

that no conflict is present

 

Alessia

Pepe

Speaker

Circle Cardiovascular Imaging B.V.

Speakers Bureau

The COI subcommittee has reviewed all financial disclosures and the content of this activity and determine

that no conflict is present

Steffen

Petersen

Speaker

NA

NA

The COI subcommittee has reviewed all financial disclosures and the content of this activity and determine

that no conflict is present

Stefan

Piechnik

Moderator

General Electric

Research Grant Overall Principal Investigator

The COI subcommittee has reviewed all financial disclosures and the content of this activity and determine

that no conflict is present

Vikas

Rathi

Speaker

NA

NA

The COI subcommittee has reviewed all financial disclosures and the content of this activity and determine

that no conflict is present

Damian

Tyler

Speaker

NA

NA

The COI subcommittee has reviewed all financial disclosures and the content of this activity and determine

that no conflict is present

 

Course Information
Course Date:
April 20, 2024
Session 1: Basics of MRI
  • Basic MRI Physics

  • Basic Pulse Sequences for MR Imaging

  • Principles of Fast Imaging

  • MRI Safety

  • CMR and Devices - Patient Preparation, Safety and Artifacts

Speaker Information
Vanessa Ferreira MD   [ view bio ]
Peter Kellman PhD  [ view bio ]
Chrisptopher Macgowan  [ view bio ]
Charlotte Manisty MD, PhD  [ view bio ]
Rebecca Mills MSc  [ view bio ]
Kevin Steel DO, FSCMR  [ view bio ]
Damian Tyler PhD  [ view bio ]
Session 2: Select and Perform Patient-Specific Protocols
  • Cine Imaging
  • LGE Imaging
  • CMR Stress Perfusion Imaging
  • CMR for Flow Quantification
  • Optimizing Image Quality and Troubleshooting
  • Recognizing and Minimizing Common Artifacts
Speaker Information
Alison Fletcher FSCMR  [ view bio ]
Dinesh Kalra MD, FSCMR  [ view bio ]
Steve Leung MD, FSCMR  [ view bio ]
Saul G. Myerson MD  [ view bio ]
Kevin Steel DO, FSCMR  [ view bio ]
Session 3: Interpret CMR Exams: Ischemic and Nonischemic Heart Disease

 

  • T1 & T2 Mapping
  • CMR for Assessing Acute Coronary Syndromes
  • CMR in Acute Myocarditis and the Lake Louise Criteria
  • Pericardial disease
  • CMR for cardiac involvement in systemic diseases and infections
  • CMR for assessing cardiac masses and tumors
Speaker Information
Erica Dall'Armellina MD, PhD  [ view bio ]
Vanessa Ferreira MD, PhD  [ view bio ]
Matthias G. Friedrich MD  [ view bio ]
Faisal Nabi MD  [ view bio ]
Ntobeko Ntusi MD, PhD  [ view bio ]
Vikas Rathi MD  [ view bio ]
Session 4: Interpret CMR Exams: Nonischemic Heart Disease, Pericardial Disease, Cardiac Masses
  • CMR for Assessing HCM
  • CMR for assessing DCM and ARVC
  • CMR for Infiltrative and Storage Heart Disease
  • CMR for assessing non-compaction Cardiomyopathy
  • CMR for Iron Overload
  • CMR for Differentiating Athlete's Heart from Cardiomyopathies
Speaker Information
Andrew Ertel MD  [ view bio ]
Marianna Fontana MD, PhD  [ view bio ]
Pier Giorgio Masci MD  [ view bio ]
Christopher Kramer MD  [ view bio ]
Viviana Maestrini MD, PhD  [ view bio ]
Karen Ordovas MD  [ view bio ]
Steffen Petersen MD  [ view bio ]
Session 5: Valvular Heart Disease and Congenital Heart Disease
  • CMR for Valvular Heart Disease
  • CMR for Basic Congenital Heart Disease
  • MCMR for Complex Congenital Heart Disease
  • CMR for Shunts
Speaker Information
Sonya V. Babu-Narayan MD, PhD, BSc  [ view bio ]
Kristian Mortensen  [ view bio ]
Saul G. Myerson MD  [ view bio ]
Rachel M. Wald MD  [ view bio ]
Session 6: Interpret CMR Exams: Vascular Diseases
  • CMR for Assessing Aortic Diseases
  • CMR for Assessing Pulmonary Arteries and Veins
  • CMR for Assessing Coronary Arteries
  • CMR for Assessing Peripheral Vascular Disease
  • Extracardiac and Extravascular Findings
     
Speaker Information
James Carr MD  [ view bio ]
Marco Francone MD, PhD  [ view bio ]
Karen Ordovas MD  [ view bio ]
Alessia Pepe MD, PhD  [ view bio ]
Individual topic purchase: Selected
Physician
AMA PRA Category 1 Credit(s)™: 17.50
Non-Physician
AMA PRA Category 1 Credit(s)™: 17.50
Products
Recordings
SCMR Member Price:$300.00
Non-Member Price:$350.00